S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
New York goes dark, then America. (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
SHOCKING Crypto Leak… (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
New York goes dark, then America. (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
SHOCKING Crypto Leak… (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
New York goes dark, then America. (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
SHOCKING Crypto Leak… (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
New York goes dark, then America. (Ad)
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
A.I. Pioneer Issues Urgent Warning to Americans (Ad)
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
SHOCKING Crypto Leak… (Ad)
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Closing prices for crude oil, gold and other commodities
Free Trial
LON:ROQ

Roquefort Therapeutics (ROQ) Share Price, News & Analysis

→ Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad)
Free ROQ Stock Alerts
GBX 4.75
0.00 (0.00%)
(As of 04/19/2024 ET)
Compare
Today's Range
4.50
▼
4.75
50-Day Range
4
▼
9.25
52-Week Range
3.90
▼
9.50
Volume
329,690 shs
Average Volume
319,000 shs
Market Capitalization
£6.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsHeadlinesInsider Trades
ROQ stock logo

About Roquefort Therapeutics Stock (LON:ROQ)

Roquefort Therapeutics plc, a biotechnology company, engages in the development of medicines for the treatment of cancer. The company's pre-clinical development pipeline comprises Midkine antibodies with significance in vivo efficacy and toxicology studies; Midkine RNA therapeutics with novel anti-cancer gene editing action; Midkine mRNA therapeutics with novel anti-cancer approach; STAT-6 siRNA therapeutics targeting solid tumors with significance in vivo efficacy; and MK cell therapy with direct and NK-mediated anti-cancer action. Roquefort Therapeutics plc was incorporated in 2020 and is based in London, the United Kingdom.

ROQ Stock Price History

ROQ Stock News Headlines

April 19, 2024 | americanbankingnews.com
Roquefort Therapeutics (LON:ROQ) Trading Down 1.1%
April 5, 2024 | msn.com
UK Stocks: Here’s Why Roquefort (ROQ) Share Price is Crashing
April 20, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
March 11, 2024 | lse.co.uk
Roquefort celebrates "significant milestones" in cancer research
March 11, 2024 | uk.investing.com
Roquefort Therapeutics reveals progress with liver and colorectal cancer programmes
December 21, 2023 | seekingalpha.com
NBSE NeuBase Therapeutics, Inc.
November 6, 2023 | lse.co.uk
Roquefort Therapeutics MK cell programme shows positive results
September 27, 2023 | proactiveinvestors.com
Roquefort Therapeutics preparing targets for clinic as eyes commercial deals
April 20, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
September 27, 2023 | proactiveinvestors.com
Roquefort Therapeutics preparing targets for clinic as it eyes commercial deals
August 17, 2023 | finance.yahoo.com
Roquefort Therapeutics seeks to lock in future value with anti-cancer therapeutic patents
August 9, 2023 | finance.yahoo.com
Roquefort Therapeutics making headway with siRNA
June 29, 2023 | proactiveinvestors.com
Roquefort Therapeutics highlights significant progress at AGM
June 22, 2023 | proactiveinvestors.com
Roquefort Therapeutics hails significant pre-clinical results
June 22, 2023 | marketwatch.com
Roquefort Therapeutics Makes Progress on Cancer Treatment
June 16, 2023 | finance.yahoo.com
Roquefort Therapeutics returns to the market with new study data
June 13, 2023 | marketwatch.com
Roquefort Therapeutics' Anti-Cancer MRNA Study Showed Positive Results
June 7, 2023 | marketwatch.com
Roquefort Therapeutics Resumes Trading After Publishing 2022 Results
June 5, 2023 | proactiveinvestors.com
Roquefort Therapeutics eyes second half progress
March 13, 2023 | proactiveinvestors.com
Roquefort Therapeutics has no exposure to SVB
March 8, 2023 | proactiveinvestors.com
Roquefort Therapeutics says new mRNA platform "fits very well"
March 8, 2023 | proactiveinvestors.com
Roquefort develops a fifth programme using a technology pioneered by Moderna and BioNTech
March 6, 2023 | proactiveinvestors.com
Roquefort Therapeutics establishes scientific advisory board
February 22, 2023 | lse.co.uk
Roquefort Thera Regulatory News
February 21, 2023 | barrons.com
Roquefort Therapeutics PLC
February 20, 2023 | proactiveinvestors.com
Roquefort Therapeutics inks Randox diagnostic deal
February 20, 2023 | proactiveinvestors.com
Roquefort Therapeutics inks first strategic licensing deal with diagnostics firm Randox
See More Headlines
Receive ROQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Roquefort Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:ROQ
CUSIP
N/A
CIK
N/A
Web
www.roquefortinvest.com
Phone
44 20 3290 9339
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-1,640,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.20%
Return on Assets
-19.04%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.66
Quick Ratio
3.07

Sales & Book Value

Annual Sales
£637.00
Price / Sales
9,630.49
Cash Flow
GBX 3.18 per share
Price / Cash Flow
1.49
Book Value
GBX 5 per share
Price / Book
0.95

Miscellaneous

Outstanding Shares
129,150,000
Free Float
N/A
Market Cap
£6.13 million
Optionable
Not Optionable
Beta
-0.03
Beginner's Guide to Pot Stock Investing Cover
Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Stephen Paul West B.Com (Age 52)
    CA, Executive Chairman
    Comp: $118.31k
  • Mr. Trevor Ajanthan Reginald (Age 52)
    CEO & Executive Director
    Comp: $284.1k
  • Prof. Martin J. Evans FRS (Age 83)
    Group Chief Scientific Officer & Executive Director
    Comp: $101.22k
  • Dr. Emma Morris
    Head of Pre-Clinical Research

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

ROQ Stock Analysis - Frequently Asked Questions

How have ROQ shares performed in 2024?

Roquefort Therapeutics' stock was trading at GBX 7.25 at the beginning of 2024. Since then, ROQ shares have decreased by 34.5% and is now trading at GBX 4.75.
View the best growth stocks for 2024 here.

How do I buy shares of Roquefort Therapeutics?

Shares of ROQ stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ROQ) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
SHOCKING Crypto Leak…
Crypto 101 Media
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets